Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0W8NK
|
|||
Former ID |
DNC014323
|
|||
Drug Name |
9-Ethyl-2-methyl-beta-carboline-2-ium iodide
|
|||
Synonyms |
CHEMBL1097826
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H15N2+
|
|||
Canonical SMILES |
CCN1C2=CC=CC=C2C3=C1C=[N+](C=C3)C
|
|||
InChI |
1S/C14H15N2/c1-3-16-13-7-5-4-6-11(13)12-8-9-15(2)10-14(12)16/h4-10H,3H2,1-2H3/q+1
|
|||
InChIKey |
UYPDJRFFVNWZQV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Acetylcholinesterase (AChE) | Target Info | Inhibitor | [1] |
Cholinesterase (BCHE) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Glycerophospholipid metabolism | |||
Cholinergic synapse | ||||
Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
Nicotinic acetylcholine receptor signaling pathway | ||||
Pathwhiz Pathway | Phospholipid Biosynthesis | |||
Pathway Interaction Database | ATF-2 transcription factor network | |||
WikiPathways | Monoamine Transport | |||
Biogenic Amine Synthesis | ||||
Acetylcholine Synthesis | ||||
Integrated Pancreatic Cancer Pathway | ||||
Irinotecan Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents. J Med Chem. 2010 May 13;53(9):3611-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.